Company: TVRD
Filing Date: 2025-10-07
Form Type: S-1/A
Source: 0001104659-25-097519
Chunk: 139

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-07
Form: S-1/A
Chunk 139
---
 ​ | ​    |       — | ​ | ​      |  7,159 | ​ |     n/a | ​ |
| Net income (loss)          | ​ | $            |  4,167 | ​ | $    | -6,975 | ​ | $      | 11,142 | ​ |  -159.7 | % | $          |  -5,412 | ​ | $    | -11,177 | ​ | $      |  5,765 | ​ |   -51.6 | % |

Research and Development Expenses Research and development expenses for the three and six months ended June 30, 2025 and 2024 were comprised of the following (in thousands, except percentages):

| ​                                                    
 ​                                                    
 ​                                                    
 Direct research and development expenses by program: 
 TTI-101:                                             | ​ 
 ​ 
 ​ 
 ​ | ​            
 Three Months 
 Ended        
 June 30,     
 2025         
 ​            
 ​            |     ​ 
     ​ 
     ​ | ​ 
 ​ 
 ​ | ​    
 2024 
 ​    
 ​    |     ​ 
     ​ 
     ​ | ​ 
 ​ 
 ​ 
 ​ | ​      
 ​      
 Change 
 Amount 
 ​      
 ​      |      ​ 
      ​ 
      ​ | ​ 
 ​ 
 ​ |       ​ 
       ​ 
 Percent 
       ​ 
       ​ | ​ 
 ​ 
 ​ 
 ​ | ​          
 Six Months 
 Ended      
 June 30,   
 2025       
 ​          
 ​          |     ​ 
     ​ 
     ​ | ​ 
 ​ 
 ​ | ​    
 2024 
 ​    
 ​    |      ​ 
      ​ 
      ​ | ​ 
 ​ 
 ​ 
 ​ | ​      
 ​      
 Change 
 Amount 
 ​      
 ​      |      ​ 
      ​ 
      ​ | ​ 
 ​ 
 ​ |       ​ 
       ​ 
 Percent 
       ​ 
       ​ | ​ 
 ​ 
 ​ 
 ​ |
|:-----------------------------------------------------|:--|:-------------|------:|:--|:-----|------:|:--|:-------|-------:|:--|--------:|:--|:-----------|------:|:--|:-----|-------:|:--|:-------|-------:|:--|--------:|:--|
| HCC                                                  | ​ | $            |   967 | ​ | $    | 1,